• Je něco špatně v tomto záznamu ?

Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat

P. Aronsson, R. Vesela, M. Johnsson, Y. Tayem, V. Wsol, M. Winder, G. Tobin,

. 2014 ; 2014 (-) : 359179.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014175

Nitric oxide (NO) has pivotal roles in cyclophosphamide- (CYP-) induced cystitis during which mucosal nitric oxide synthase (NOS) and muscarinic M5 receptor expressions are upregulated. In cystitis, urothelial muscarinic NO-linked effects hamper contractility. Therefore we wondered if a blockade of this axis also affects the induction of cystitis in the rat. Rats were pretreated with saline, the muscarinic receptor antagonist 4-DAMP (1 mg/kg ip), or the NOS inhibitor L-NAME (30 mg/kg ip) for five days. 60 h before the experiments the rats were treated with saline or CYP. Methacholine-, ATP-, and adenosine-evoked responses were smaller in preparations from CYP-treated rats than from saline-treated ones. Pretreatment with 4-DAMP did not change this relation, while pretreatment with L-NAME normalized the responses in the CYP-treated animals. The functional results were strengthened by the morphological observations; 4-DAMP pretreatment did not affect the parameters studied, namely, expression of muscarinic M5 receptors, P1A1 purinoceptors, mast cell distribution, or bladder wall enlargement. However, pretreatment with L-NAME attenuated the differences. Thus, the current study provides new insights into the complex mechanisms behind CYP-induced cystitis. The NO effects coupled to urothelial muscarinic receptors have a minor role in the development of cystitis. Inhibition of NOS may prevent the progression of cystitis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014175
003      
CZ-PrNML
005      
20150421092128.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2014/359179 $2 doi
035    __
$a (PubMed)24982868
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Aronsson, Patrik $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden. $7 gn_A_00008807
245    10
$a Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat / $c P. Aronsson, R. Vesela, M. Johnsson, Y. Tayem, V. Wsol, M. Winder, G. Tobin,
520    9_
$a Nitric oxide (NO) has pivotal roles in cyclophosphamide- (CYP-) induced cystitis during which mucosal nitric oxide synthase (NOS) and muscarinic M5 receptor expressions are upregulated. In cystitis, urothelial muscarinic NO-linked effects hamper contractility. Therefore we wondered if a blockade of this axis also affects the induction of cystitis in the rat. Rats were pretreated with saline, the muscarinic receptor antagonist 4-DAMP (1 mg/kg ip), or the NOS inhibitor L-NAME (30 mg/kg ip) for five days. 60 h before the experiments the rats were treated with saline or CYP. Methacholine-, ATP-, and adenosine-evoked responses were smaller in preparations from CYP-treated rats than from saline-treated ones. Pretreatment with 4-DAMP did not change this relation, while pretreatment with L-NAME normalized the responses in the CYP-treated animals. The functional results were strengthened by the morphological observations; 4-DAMP pretreatment did not affect the parameters studied, namely, expression of muscarinic M5 receptors, P1A1 purinoceptors, mast cell distribution, or bladder wall enlargement. However, pretreatment with L-NAME attenuated the differences. Thus, the current study provides new insights into the complex mechanisms behind CYP-induced cystitis. The NO effects coupled to urothelial muscarinic receptors have a minor role in the development of cystitis. Inhibition of NOS may prevent the progression of cystitis.
650    _2
$a adenosin $x farmakologie $7 D000241
650    _2
$a adenosintrifosfát $x farmakologie $7 D000255
650    _2
$a zvířata $7 D000818
650    _2
$a cyklofosfamid $7 D003520
650    _2
$a cystitida $x farmakoterapie $x patologie $x patofyziologie $7 D003556
650    _2
$a inhibitory enzymů $x farmakologie $x terapeutické užití $7 D004791
650    _2
$a imunohistochemie $7 D007150
650    _2
$a techniky in vitro $7 D066298
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mastocyty $x účinky léků $x patologie $7 D008407
650    _2
$a methacholinchlorid $x farmakologie $7 D016210
650    _2
$a svalová kontrakce $x účinky léků $7 D009119
650    _2
$a synthasa oxidu dusnatého $x antagonisté a inhibitory $x metabolismus $7 D019001
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a receptory muskarinové $x metabolismus $7 D011976
650    _2
$a purinergní receptory $x metabolismus $7 D011983
650    _2
$a močový měchýř $x účinky léků $x patologie $x patofyziologie $7 D001743
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vesela, Renata $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden ; Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic.
700    1_
$a Johnsson, Martin $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden.
700    1_
$a Tayem, Yasin $u Department of Physiology and Pharmacology, Faculty of Medicine, Al-Quds University, P.O. Box 51000, Jerusalem, West Bank, Palestine.
700    1_
$a Wsol, Vladimir $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic.
700    1_
$a Winder, Michael $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden.
700    1_
$a Tobin, Gunnar $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden.
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2014, č. - (2014), s. 359179
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24982868 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150421092426 $b ABA008
999    __
$a ok $b bmc $g 1071756 $s 897053
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 2014 $c - $d 359179 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...